BioAtla, Inc.
BCAB
$4.54
$0.020.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.61M | -64.71M | -59.52M | -61.88M | -69.78M |
| Total Depreciation and Amortization | 373.00K | 582.00K | 754.00K | 868.00K | 925.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.07M | 5.97M | 4.76M | 5.58M | 8.11M |
| Change in Net Operating Assets | 4.96M | 1.08M | 1.68M | -1.97M | -11.20M |
| Cash from Operations | -48.20M | -57.07M | -52.32M | -57.40M | -71.94M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 7.13M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.00K | 9.36M | 9.36M | 9.56M | 9.56M |
| Repurchase of Common Stock | -52.00K | -40.00K | -48.00K | -62.00K | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -897.00K | -444.00K | -444.00K | -366.00K | -- |
| Cash from Financing | 6.28M | 8.88M | 8.87M | 9.13M | 9.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.93M | -48.20M | -43.46M | -48.27M | -62.43M |